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Abstract The bipartite human interleukin-4 (IL-4) receptor was
functionally expressed in murine pro-B cells and activated by
human IL-4 to evoke intracellular signaling. Mutual association
of signal transducing proteins within the receptor complex was
then studied in dependence of ligand stimulation. Besides ligand-
induced receptor heterodimerization and contacts of the two IL-4
receptor subunits K and Q with Janus kinases JAK1 and JAK3 a
prominent constitutive binding between JAK1 and signal
transducer and activator of transcription STAT5 was detected.
Since both these proteins become phosphorylated in response to
IL-4 receptor stimulation, the influence of tyrosine phosphoryla-
tion on their mutual contact was analyzed. Association of JAK1
and STAT5 was found to occur exclusively between unphos-
phorylated proteins.
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1. Introduction
Interleukin-4 (IL-4), a multifunctional immune regulator,
exerts its activity on target cells via the bipartite IL-4 receptor,
which consists of the interleukin-4 receptor K-chain (IL-4RK)
[1], and the common Q-receptor chain (Qc) [2,3]. Both receptor
subunits are members of the cytokine receptor superfamily
characterized by common structural [4] as well as functional
properties [5].
Ligand-induced juxtaposition of cytoplasmic receptor do-
mains triggers intracellular signal release and ultimately leads
to cellular responses such as di¡erentiation and proliferation.
Heterodimers of IL-4RK and Qc [2] as well as experimentally
induced homotypic dimers of IL-4RK [6,7] can mediate the
activation of various proteins involved in signal transfer from
the cell membrane to the nucleus. Of key importance in this
course of events is the coordination of speci¢c tyrosine phos-
phorylation processes. Phosphorylation is operative in modu-
lating the interactions between signaling proteins associated
with the IL-4 receptor complex.
Upon IL-4 receptor chain dimerization, Janus kinases
JAK1 and JAK3, which are already preassociated to the K-
and Q-chain, respectively [8,9], are activated and become sub-
ject to autophosphorylation and/or transphosphorylation.
Subsequently, various tyrosine residues within the cytoplasmic
domains of the receptor chain as well as in associated signal-
ing mediators become phosphorylated by the JAK kinases
and probably to some extent also by the action of src type
kinases. As a result of these reactions, a network of protein-
protein interactions within the receptor complex and its vicin-
ity is created that relies on contacts between protein recogni-
tion domains and phosphotyrosine-containing cognate se-
quence motifs within their binding partners.
The best characterized signaling transduction cascade trig-
gered by the IL-4 receptor is the JAK/STAT pathway. Where-
as STAT6 is known for several years to be a characteristic
mediator of IL-4 signaling [10], we have recently shown that
the IL-4 receptor is also able to activate STAT5 [11]. The
mechanisms of STAT5 activation through the IL-4R have
not yet been characterized.
In this study we have approached IL-4-induced signal trans-
duction leading to STAT5 activation by an analysis of pro-
tein-protein interactions within the receptor complex. Copre-
cipitation experiments did not allow for the detection of an
IL-4-evoked direct contact between STAT5 and either of the
IL-4 receptor subunits. Instead, a prominent constitutive as-
sociation between STAT5 and JAK1 was observed. This in-
teraction showed a striking dependence on the tyrosine phos-
phorylation state of both proteins. These ¢ndings add novel
mechanistical aspects to the understanding of IL-4-triggered
activation of STAT5. In addition, they raise interesting spec-
ulations on the functional implications of tyrosine phosphor-
ylation reactions in the temporal organization of ligand-in-
duced signal transduction in cytokine receptor complexes.
2. Materials and methods
2.1. Cell culture and IL-4 stimulation of cells
The previously described cell line BAF-4K-pQ [6,12] is a derivative
of the IL-3-dependent murine pro-B cell line Ba/F3 and stably ex-
presses both subunits of the human IL-4 receptor. An aminoterminal
epitope tag was fused to the human Qc receptor chain that allows for
speci¢c immunoprecipitation of the heterologous receptor by using
antibody P5D4 [12]. Cells were cultivated as described [6,12].
For cytokine stimulation experiments, samples of 3U107 cells were
starved from murine IL-3 for 2 h and then incubated at 37‡C for 10
min in 1 ml of medium containing no cytokine, or 7 nM of recombi-
nant human IL-4 (a gift from W. Sebald, Wuºrzburg).
2.2. Immunoprecipitation and immunoblotting
Samples of starved or cytokine-treated cells were pelleted and sub-
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jected to cell lysis and immunoprecipitation as described [6,12].
Cleared lysates were incubated with 1^5 Wg of speci¢c antibody for
3 h at 4‡C. Mouse monoclonal antibodies used were X14/38 to hIL-
4RK [13], P5D4 recognizing epitope-tagged human Qc [12] and E34-1
directed to murine JAK3 [14]. Rabbit antisera used were anti-JAK1
(Transduction Laboratories) and anti-STAT5a [15]. Immunocom-
plexes were collected from lysates with 20 Wl of anti-mouse-IgG-agar-
ose or protein A-Sepharose (Sigma) and assayed by Western blot as
described [12] using peroxidase-coupled anti-pTyr antibody RC20
(Transduction Laboratories) or the above-mentioned primary anti-
bodies and peroxidase-coupled anti-mouse and anti-rabbit IgG (Sig-
ma) for detection. Immunoreactive bands were visualized by enhanced
chemiluminescence (Amersham). Stripping of blots for reprobing was
done by incubating the membranes with 0.1 M glycine, pH 2.9, at
room temperature for 20 min (for RC20), or with 62.5 M Tris-HCl,
pH 8.5, 100 mM L-mercaptoethanol, 2% SDS at 50‡C for 30 min (for
all other antibodies) followed by extended washing.
3. Results and discussion
3.1. Analysis of protein-protein interactions within the IL-4
receptor complex reveals a constitutive association between
STAT5 and JAK1
We have recently demonstrated the activation of STAT5a
and STAT5b through the human IL-4 receptor (hIL-4R) [11].
To gain insight into molecular mechanisms underlying this
signaling pathway, we wished to determine which protein-pro-
tein interactions are involved in the contact between STAT5
and the IL-4 receptor. To this end, we employed a Ba/F3-
derived cell line stably expressing a functional bipartite human
IL-4R that consists of hIL-4RK and human Qc with an amino-
terminally fused epitope tag (BAF-4K-pQ) [6,12]. We per-
formed immunoprecipitations from lysates of both starved
and hIL-4-stimulated BAF-4K-pQ cells using antibodies to var-
ious constituents of the hIL-4R complex. Precipitates ob-
tained with antibodies to human IL-4RK, epitope-tagged hu-
man Qc, JAK1, JAK3, and STAT5a were subjected to Western
blot analysis (Fig. 1). Controls employing only protein A-Se-
pharose or anti-mouse IgG agarose were included to rule out
any possible unspeci¢c precipitations (lanes 1^4). We ¢rst
probed blots resulting from the indicated Ipps with
anti-STAT5a in order to identify interaction partners among
the components of the receptor assembly (panel I). Apart
from the anti-STAT5 precipitates serving as a positive control
in this test (lanes 13 and 14), a strong STAT5a signal was
observed in anti-JAK1 precipitates from both untreated and
stimulated cells (lanes 9 and 10), indicating a speci¢c interac-
tion of the two proteins. No coprecipitation of STAT5a with
hIL-4K, Qc or JAK3 could be detected. The blot was subse-
quently stripped from anti-STAT5a and reprobed with anti-
JAK1 and, in order to control for successful precipitations
and equal loading, with anti-hIL-4RK, anti-JAK3 and anti-
Qc (panels II^V). As expected, an intense JAK1 signal was
seen in the anti-JAK1 precipitates (panel II, lanes 9 and 10).
Again indicating a speci¢c binding between JAK1 and
STAT5a, JAK1 was coprecipitated by anti-STAT5a (lanes
13 and 14). Coprecipitation of JAK1 with anti-STAT5a
yielded clear, but much weaker signals than the reverse experi-
ment. We attribute this ¢nding to the fact that in Ba/F3 cells
STAT5a is by far more abundant than JAK1 (data not
shown). The weak expression level of Janus kinases and
both hIL-4 receptor subunits could also be the reason why
a coprecipitation of JAK1 with hIL-4RK and JAK3 with epi-
tope-tagged Qc, respectively, could not be detected on the
original blots that had previously undergone incubation with
anti-STAT5a and removal of this antibody (data not shown).
Similar di⁄culties were encountered with attempts to show
coprecipitation of IL-4RK with Qc. To still demonstrate these
various protein-protein contacts, the delicate Ipps and sub-
sequent Western blots (marked with a triangle) were per-
formed again separately and subjected immediately to detec-
tion with the respective antibodies without prior stripping.
Negative controls without antibodies were always included
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Fig. 1. Analysis of protein-protein interactions in the hIL-4 receptor complex in BAF-4K-pQ cells by coimmunoprecipitations. Starved cells were
either left untreated or stimulated with 7 nM hIL-4 as indicated. From lysates immunoprecipitations were performed applying the antibodies in-
dicated in the top row. As speci¢city controls, precipitations with protein A-Sepharose and anti-mouse IgG were included. Precipitates were
subjected to SDS-PAGE and Western blot. The membranes were probed with anti-STAT5a and then successively with antibodies to JAK1,
hIL-4RK, epitope-tagged hQc, and JAK3 as indicated to the left. Sections marked with a ¢lled triangle were derived from separate blots that
had not undergone previous detections with other antibodies (for details see text).
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to assure speci¢city (data not shown). In this way, constitutive
associations between receptor chains and JAK kinases (panel
II, lanes 5 and 6; panel IV, lanes 11 and 12; panel V, lanes 9
and 10) as well as ligand-dependent intersubunit contacts
(panel III, lanes 9 and 10; panel IV, lanes 5 and 6) could
readily be detected.
These results comprehensively mirror protein-protein inter-
actions that underlie the IL-4-driven JAK/STAT5 pathway(s).
Interestingly, no ligand-induced association of STAT5 with the
IL-4 receptor chains that would be stable enough to result in
coimmunoprecipitation could be detected. Instead, we ob-
served an intense and constitutive binding of STAT5 to
JAK1. Examples have emerged for STAT activation without
the apparent necessity for phosphotyrosines on the side of the
activated receptor [16,17]. Tyrosine phosphorylation of the re-
ceptors for GM-CSF and EPO are dispensable for at least some
degree of ligand-induced STAT5 phosphorylation and activa-
tion [16,18]. We could recently show that activation of STAT6
is not dependent on tyrosine residues contained in the sequence
of IL-4RK chain [19] and have also observed that STAT5 does
not require IL-4RK tyrosine phosphorylation (Friedrich et al.,
submitted for publication). Together with results presented in
this work, these earlier ¢ndings point to a possible function of
the STAT5-JAK1 complex in IL-4R signal transduction. Our
data and interpretations are in full agreement with a publica-
tion by Fujitani et al., who identi¢ed STAT5 as a major bind-
ing partner for JAK1 in two-hybrid screen and demonstrated
that STAT5, unlike STAT3, cannot be coprecipitated with the
cytokine receptor subunit gp130 [20]. Moreover, these authors
could show that phosphotyrosines on the side of the receptor
were not essential for STAT5 activation and concluded that
signaling can occur through the immediate interaction of
STAT5 with gp130-bound JAK1.
3.2. Association of JAK1 and STAT5 occurs exclusively
between unphosphorylated proteins
Since STAT5 had been found to contact JAK1 in BAF-4K-
pQ cells irrespective of hIL-4 stimulation and this association
is of possible importance for signaling, we were interested to
assess to what extent IL-4-induced tyrosine phosphorylation
of the two binding partners in£uences their mutual interac-
tion. Anti-JAK1 immunoprecipitates from lysates of starved
and hIL-4-stimulated BAF-4K-pQ cells were analyzed for ty-
rosine phosphorylated proteins by Western blot (Fig. 2A). A
single phosphorylated protein in the size range of 120 kDa
appeared upon hIL-4 stimulation which by reprobing of the
blot (Fig. 2B) with anti-JAK1 was proven to be JAK1. No
tyrosine phosphorylation of proteins in the size range of 90
kDa was detectable (Fig. 2A), but reprobing of the blot with
an antibody to STAT5 demonstrated that considerable
amounts of STAT5 had been coprecipitated with JAK1
(Fig. 2C). To more thoroughly analyze the e¡ect of tyrosine
phosphorylation on the interaction between STAT5 and
JAK1, we also performed the reverse experiment, i.e. immu-
noprecipitates obtained with anti-STAT5 were consecutively
probed with anti-pTyr (Fig. 3A), anti-STAT5 (Fig. 3B) and
anti-JAK1 (Fig. 3C). In accordance with the data documented
in Fig. 2, JAK1 was present in the anti-STAT5 precipitates
only in its unphosphorylated form (Fig. 3C); it could not be
detected by anti-pTyr (Fig. 3A).
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Fig. 3. E¡ect of JAK1 tyrosine phosphorylation on the protein-protein interaction with STAT5. Starved BAF-4K-pQ cells were left untreated or
stimulated with hIL-4 as indicated and subjected to immunoprecipitation with anti-STAT5 followed by Western blot. The blot was successively
probed with antibodies to (A) pTyr, (B) STAT5 and (C) JAK1.
Fig. 2. E¡ect of STAT5 tyrosine phosphorylation on the protein-protein interaction with JAK1. Starved BAF-4K-pQ cells were left untreated or
stimulated with hIL-4 as indicated and subjected to immunoprecipitation with anti-JAK1 followed by Western blot. The blot was successively
probed with antibodies to (A) pTyr, (B) JAK1 and (C) STAT5.
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We conclude from the two complementary precipitation
experiments that tyrosine phosphorylation of JAK1 and/or
STAT5 precludes their binding to each other. In functional
terms of cytokine signaling, we interpret these results such
that the mechanism of STAT5 activation by JAK1 involves
a rapid release of the STAT protein from the contact with the
kinase once both proteins have become tyrosine phosphoryl-
ated upon activation of the receptor system. Fujitani et al.,
who have ¢rst demonstrated a direct interaction between
STAT5 and JAK1 [20], did not address the in£uence of tyro-
sine phosphorylation of the two proteins on their mutual con-
tact. By deletion analysis these authors have shown that a
determinant located in the amino acid 680^688 region of
STAT5 is critical for binding to JAK1. Interestingly, Y694,
the major phosphoacceptor site in the STAT5 molecule, is not
essential for this association. This ¢nding implies that tyrosine
phosphorylation of STAT5 does not regulate its a⁄nity for
JAK1 in a positive fashion. It is, however, conceivable that
the regulatory tyrosine at position 694 may have a negative
in£uence on JAK1 binding upon phosphorylation. In its phos-
phorylated form it promotes dimerization of STAT5 through
pTyr-SH2 domain crossbridging between two individual mol-
ecules [21]. As a consequence of this event, a nearby JAK
contact interface could be distorted, leading to the dissolution
of the JAK/STAT association.
On the side of the JAKs, the JH2 or pseudokinase domain
proved the crucial substructure for the interaction with
STAT5 [20]. Although tyrosine phosphorylation of Janus ki-
nases is correlated with activation, the underlying mechanisms
are not well understood. Catalytic activity appears to be con-
trolled by phosphorylation of two tyrosine residues within the
putative activation loop of the kinase domain, but autophos-
phorylation of the protein occurs at a multitude of addition-
al sites [22]. We do not know yet whether dissociation of
STAT5 and JAK1 results from phosphorylation of only one
or both of the proteins. Our results, however, leave open the
possibility that tyrosine phosphorylation, perhaps within
the JH2 domain, may modulate the properties of JAK1
with respect to its participation in protein-protein interac-
tions.
Recently some other cases have emerged in which tyrosine
phosphorylation mediates against intermolecular protein-pro-
tein association. The a⁄nity between erythrocyte membrane
protein band 3 and aldolase is decreased by tyrosine phos-
phorylation, probably by blocking through electrostatic repul-
sion [23,24]. Bradshaw et al. showed that interaction of the
cytoplasmic tail of CD152, a mediator of T cell activation,
with a clathrin-associated protein is negatively regulated by
tyrosine phosphorylation [25]. Various other studies employ-
ing epitope-speci¢c antibodies, protein binding assays and
structural methods have provided evidence for a determinant
in£uence of tyrosine phosphorylation on protein conforma-
tion [26^31].
For serine/threonine phosphorylation, versatile regulative
functions in intracellular information transfer are well estab-
lished. Likewise, the role of protein tyrosine phosphorylation
clearly appears to exceed positive control involving SH2 and
PTB domains where phosphorylation is required for binding.
Future studies will unravel to what extent negative regulation
of protein-protein interactions by tyrosine phosphorylation is
a mechanism operative in signal transduction in general and
in cytokine receptor signaling in particular.
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